ID

42354

Descripción

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01578499

Link

https://clinicaltrials.gov/show/NCT01578499

Palabras clave

Versiones (1)
  1. 22/6/21 22/6/21 -
Titular de derechos de autor

Millennium Pharmaceuticals, Inc. Seagen Inc.

Subido en

22 de junio de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Primary Cutaneous Anaplastic Large Cell Lymphoma, NCT01578499

Inglés

Eligibility Primary Cutaneous Anaplastic Large Cell Lymphoma, NCT01578499

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
voluntary consent form
Descripción

Informed consent voluntary

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439656
male or female patients 18 years or older with diagnosis of mf or pcalcl
Descripción

Age | Mucosis fungoides | Primary cutaneous anaplastic large cell lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0026948
UMLS CUI [2,1]
C0001779
UMLS CUI [2,2]
C1301362
patients with pcalcl who have received prior radiation therapy or at least 1 prior systemic therapy; patients with mf who have received at least 1 prior systemic therapy
Descripción

Patients with pcalcl who have received prior radiation therapy or at least 1 prior systemic therapy | Patients with mf who have received at least 1 prior systemic therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301362
UMLS CUI [1,2]
C0279134
UMLS CUI [2,1]
C1301362
UMLS CUI [2,2]
C1515119
UMLS CUI [2,3]
C0332152
UMLS CUI [3,1]
C0026948
UMLS CUI [3,2]
C1515119
UMLS CUI [3,3]
C0332152
histologically confirmed cd30+ disease by central laboratory assessment and pathology review
Descripción

CD30+ disease histologically confirmed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3888910
UMLS CUI [1,2]
C0750484
UMLS CUI [1,3]
C0030664
eastern cooperative oncology group (ecog) performance status ≤ 2
Descripción

Eastern cooperative oncology group (ecog) performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
female patients who are post menopausal, surgically sterile, or agree to practice 2 effective methods of contraception or agree to practice true abstinence, when this is in line with the preferred and usual lifestyle of the subject
Descripción

Postmenopausal state | Surgically sterile | Willing to practise 2 effective contraceptive methods | Willing to practise sexual abstinence

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0015787
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0600109
UMLS CUI [4,1]
C0036899
UMLS CUI [4,2]
C0600109
male patients who agree to practice effective barrier contraception or agree to practice true abstinence, when this is in line with the preferred and usual lifestyle of the subject
Descripción

Male patients willing to practice effective barrier contraception | Willing to practice true sexual abstinence

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004764
UMLS CUI [1,2]
C0086582
UMLS CUI [1,3]
C0600109
UMLS CUI [2,1]
C0036899
UMLS CUI [2,2]
C0086582
UMLS CUI [2,3]
C0600109
clinical laboratory values as specified in protocol
Descripción

Clinical laboratory values as specified in protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C1550543
UMLS CUI [1,3]
C0243161
UMLS CUI [1,4]
C2348563
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
a concurrent diagnosis of systemic alcl,other non hodgkin lymphoma(excluding lyp) or sezary syndrome or b2 disease
Descripción

Concurrent diagnosis of systemic aclc | Other non-hodgkin lymphoma | Sezary syndrome | B2 disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205420
UMLS CUI [1,2]
C1336548
UMLS CUI [2,1]
C0205420
UMLS CUI [2,2]
C0024305
UMLS CUI [3,1]
C0205420
UMLS CUI [3,2]
C0036920
UMLS CUI [4,1]
C0205420
UMLS CUI [4,2]
C0523880
patients with cardiovascular conditions specified in protocols
Descripción

Cardiovascular conditions specified in study protocols

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C2348563
UMLS CUI [1,3]
C0449238
patients with history of another primary malignancy not in remission for at least 3 years
Descripción

History of another primary malignancy not in remission for at least 3 years

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0006826
UMLS CUI [1,3]
C0544452
UMLS CUI [1,4]
C0332197
known active cerebral/meningeal disease, hiv infection, hepatitis b or hepatitis c infection
Descripción

Known active cerebral/meningeal disease | HIV infection | Hepatitis B | Hepatitis C infection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019693
UMLS CUI [1,2]
C0205177
UMLS CUI [2,1]
C0019163
UMLS CUI [2,2]
C0205177
UMLS CUI [3,1]
C0019196
UMLS CUI [3,2]
C0205177
UMLS CUI [4,1]
C0234387
UMLS CUI [4,2]
C0205177
UMLS CUI [5,1]
C0154728
UMLS CUI [5,2]
C0205177
oral retinoid therapy for any indication within 3 weeks of study entry
Descripción

Recent oral retinoid therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442027
UMLS CUI [1,2]
C0035339
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0332185
corticosteroid therapy within 3 weeks or immunosuppressive chemotherapy or any antibody-directed or immunoglobulin-based immune therapy (eg, immunoglobulin replacement, other monoclonal antibody therapies) within 12 weeks of first dose of study drug
Descripción

Corticosteroid therapy recent | Immunosuppresive chemotherapy recent | Antibody-directed immune therapy | Ammunoglobulin-based immune therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0149783
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C3665472
UMLS CUI [2,2]
C0332185
UMLS CUI [3,1]
C0003250
UMLS CUI [3,2]
C0021083
UMLS CUI [3,3]
C0332185
UMLS CUI [4,1]
C0021027
UMLS CUI [4,2]
C1705938
UMLS CUI [4,3]
C0021083
UMLS CUI [4,4]
C0332185
female patients who are lactating and breastfeeding or have a positive serum pregnancy test during the screening period or a positive urine pregnancy test on day 1 of any cycle
Descripción

Lactation and brestfeeding | Positive serum pregnancy test | Positive urine pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0022925
UMLS CUI [1,2]
C0006147
UMLS CUI [2,1]
C0430064
UMLS CUI [2,2]
C1446409
UMLS CUI [3,1]
C0430056
UMLS CUI [3,2]
C1446409
previous receipt of brentuximab vedotin
Descripción

Previous therapy with brentuximab vedotin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2973446
UMLS CUI [1,2]
C2114510
Volver a la parte superior de la página

Similar models

Eligibility Primary Cutaneous Anaplastic Large Cell Lymphoma, NCT01578499

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed consent voluntary
Item
voluntary consent form
boolean
C0021430 (UMLS CUI [1,1])
C0439656 (UMLS CUI [1,2])
Age | Mucosis fungoides | Primary cutaneous anaplastic large cell lymphoma
Item
male or female patients 18 years or older with diagnosis of mf or pcalcl
boolean
C0001779 (UMLS CUI [1,1])
C0026948 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2,1])
C1301362 (UMLS CUI [2,2])
Patients with pcalcl who have received prior radiation therapy or at least 1 prior systemic therapy | Patients with mf who have received at least 1 prior systemic therapy
Item
patients with pcalcl who have received prior radiation therapy or at least 1 prior systemic therapy; patients with mf who have received at least 1 prior systemic therapy
boolean
C1301362 (UMLS CUI [1,1])
C0279134 (UMLS CUI [1,2])
C1301362 (UMLS CUI [2,1])
C1515119 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C0026948 (UMLS CUI [3,1])
C1515119 (UMLS CUI [3,2])
C0332152 (UMLS CUI [3,3])
CD30+ disease histologically confirmed
Item
histologically confirmed cd30+ disease by central laboratory assessment and pathology review
boolean
C3888910 (UMLS CUI [1,1])
C0750484 (UMLS CUI [1,2])
C0030664 (UMLS CUI [1,3])
Eastern cooperative oncology group (ecog) performance status
Item
eastern cooperative oncology group (ecog) performance status ≤ 2
boolean
C1520224 (UMLS CUI [1])
Postmenopausal state | Surgically sterile | Willing to practise 2 effective contraceptive methods | Willing to practise sexual abstinence
Item
female patients who are post menopausal, surgically sterile, or agree to practice 2 effective methods of contraception or agree to practice true abstinence, when this is in line with the preferred and usual lifestyle of the subject
boolean
C0232970 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C0700589 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0600109 (UMLS CUI [3,3])
C0036899 (UMLS CUI [4,1])
C0600109 (UMLS CUI [4,2])
Male patients willing to practice effective barrier contraception | Willing to practice true sexual abstinence
Item
male patients who agree to practice effective barrier contraception or agree to practice true abstinence, when this is in line with the preferred and usual lifestyle of the subject
boolean
C0004764 (UMLS CUI [1,1])
C0086582 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
C0036899 (UMLS CUI [2,1])
C0086582 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Clinical laboratory values as specified in protocol
Item
clinical laboratory values as specified in protocol
boolean
C1254595 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
Concurrent diagnosis of systemic aclc | Other non-hodgkin lymphoma | Sezary syndrome | B2 disease
Item
a concurrent diagnosis of systemic alcl,other non hodgkin lymphoma(excluding lyp) or sezary syndrome or b2 disease
boolean
C0205420 (UMLS CUI [1,1])
C1336548 (UMLS CUI [1,2])
C0205420 (UMLS CUI [2,1])
C0024305 (UMLS CUI [2,2])
C0205420 (UMLS CUI [3,1])
C0036920 (UMLS CUI [3,2])
C0205420 (UMLS CUI [4,1])
C0523880 (UMLS CUI [4,2])
Cardiovascular conditions specified in study protocols
Item
patients with cardiovascular conditions specified in protocols
boolean
C0007222 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
History of another primary malignancy not in remission for at least 3 years
Item
patients with history of another primary malignancy not in remission for at least 3 years
boolean
C0262926 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0544452 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Known active cerebral/meningeal disease | HIV infection | Hepatitis B | Hepatitis C infection
Item
known active cerebral/meningeal disease, hiv infection, hepatitis b or hepatitis c infection
boolean
C0019693 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0019163 (UMLS CUI [2,1])
C0205177 (UMLS CUI [2,2])
C0019196 (UMLS CUI [3,1])
C0205177 (UMLS CUI [3,2])
C0234387 (UMLS CUI [4,1])
C0205177 (UMLS CUI [4,2])
C0154728 (UMLS CUI [5,1])
C0205177 (UMLS CUI [5,2])
Recent oral retinoid therapy
Item
oral retinoid therapy for any indication within 3 weeks of study entry
boolean
C0442027 (UMLS CUI [1,1])
C0035339 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
Corticosteroid therapy recent | Immunosuppresive chemotherapy recent | Antibody-directed immune therapy | Ammunoglobulin-based immune therapy
Item
corticosteroid therapy within 3 weeks or immunosuppressive chemotherapy or any antibody-directed or immunoglobulin-based immune therapy (eg, immunoglobulin replacement, other monoclonal antibody therapies) within 12 weeks of first dose of study drug
boolean
C0149783 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C3665472 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C0003250 (UMLS CUI [3,1])
C0021083 (UMLS CUI [3,2])
C0332185 (UMLS CUI [3,3])
C0021027 (UMLS CUI [4,1])
C1705938 (UMLS CUI [4,2])
C0021083 (UMLS CUI [4,3])
C0332185 (UMLS CUI [4,4])
Lactation and brestfeeding | Positive serum pregnancy test | Positive urine pregnancy test
Item
female patients who are lactating and breastfeeding or have a positive serum pregnancy test during the screening period or a positive urine pregnancy test on day 1 of any cycle
boolean
C0022925 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0430064 (UMLS CUI [2,1])
C1446409 (UMLS CUI [2,2])
C0430056 (UMLS CUI [3,1])
C1446409 (UMLS CUI [3,2])
Previous therapy with brentuximab vedotin
Item
previous receipt of brentuximab vedotin
boolean
C2973446 (UMLS CUI [1,1])
C2114510 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial